Michael Fearon

Title: Michael Fearon: Innovator in Pharmaceutical Intervention

Introduction

Michael Fearon is a notable inventor based in Annapolis Royal, Canada. He has made significant contributions to the field of pharmaceutical intervention, particularly in coagulation control. His innovative approach aims to enhance the effectiveness of medication dosages for patients requiring anticoagulation therapy.

Latest Patents

Michael Fearon holds a patent for "Methods and systems for improved pharmaceutical intervention in coagulation control." This patent outlines contemplated methods and devices that allow for a more consistent dosage of required medication. It also quantifies and accounts for patient-specific sensitivity to warfarin and Vitamin K by utilizing logit (1/INR) as the dependent variable. This approach stabilizes the variance across all values of INR, simplifying the relationship between INR and the dosage of coumarins or Vitamin K. Furthermore, it reduces the number of parameters that need to be estimated for each patient, making treatment more efficient.

Career Highlights

Throughout his career, Michael Fearon has worked with various companies, including Epitome Pharmaceuticals Limited. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to develop innovative solutions for coagulation control.

Collaborations

Michael has collaborated with professionals in his field, including his coworker Paul T Wegener. Their joint efforts have contributed to advancements in pharmaceutical interventions.

Conclusion

Michael Fearon's work in pharmaceutical intervention showcases his dedication to improving patient care through innovative solutions. His patent and career achievements reflect his commitment to advancing the field of coagulation control.